Genevive, Inc.
4Patents
4Active
4Granted
56Portfolio score
Filing activity: Jan 6, 2020 → Jul 18, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12371456B2 | Proteins for the treatment of epithelial barrier function disorders | Human Necessities | 0 | Active |
| US12186364B2 | Proteins for the treatment of epithelial barrier function disorders | Human Necessities | 0 | Active |
| US12168676B2 | Microbially derived peptides and proteins for immunotherapy | Human Necessities | 0 | Active |
| US12168677B2 | Proteins for the treatment of epithelial barrier function disorders | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.